INCY
Incyte Corporation
Company Overview
| Mkt Cap | $17.10B | Price | $93.48 |
| Volume | 2.50M | Change | +0.96% |
| P/E Ratio | 524.3 | Open | $92.70 |
| Revenue | $4.2B | Prev Close | $92.59 |
| Net Income | $32.6M | 52W Range | $53.56 - $95.10 |
| Div Yield | N/A | Target | $86.76 |
| Overall | 67 | Value | 60 |
| Quality | -- | Technical | 75 |
No chart data available
Stock Overview
Updated DailyIncyte Corporation (INCY) is a leading Healthcare company in the Biotechnology industry, currently trading at $93.48 with a market capitalization of $17.10 billion. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows INCY with a volume of 2.50 million shares. The stock opened up 0.12% from yesterday's close of $92.59. Current analyst estimates project earnings of $5.13 per share for this year, with next year targeting $6.35.
INCY demonstrates strong technical indicators based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including AMGN, LGND, LLY, PFE, GERN.
Key investment considerations for INCY include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest limited upside of -7.2%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 2, 2025 at 02:47 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | INCY | $93.48 | +1.0% | 2.50M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |